Guangzhou Improve Med Instrument
Improve Medical Instruments Co., Ltd. engages in the provision of relevant technologies, products, and services for clinical laboratory and clinical nursing in China and internationally. It provides clinical laboratory products comprising urine, feces, and thrombosis viscoelastic analysis systems; and automatic biosafety decappers; and Q-VELOX, an intelligent molecular diagnostic workstation. The… Read more
Guangzhou Improve Med Instrument (300030) - Total Assets
Latest total assets as of September 2025: CN¥1.08 Billion CNY
Based on the latest financial reports, Guangzhou Improve Med Instrument (300030) holds total assets worth CN¥1.08 Billion CNY as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Guangzhou Improve Med Instrument - Total Assets Trend (2006–2024)
This chart illustrates how Guangzhou Improve Med Instrument’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Guangzhou Improve Med Instrument - Asset Composition Analysis
Current Asset Composition (December 2024)
Guangzhou Improve Med Instrument's total assets of CN¥1.08 Billion consist of 47.4% current assets and 52.7% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 19.9% |
| Accounts Receivable | CN¥165.41 Million | 13.3% |
| Inventory | CN¥102.88 Million | 8.3% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥38.64 Million | 3.1% |
| Goodwill | CN¥7.80 Million | 0.6% |
Asset Composition Trend (2006–2024)
This chart illustrates how Guangzhou Improve Med Instrument's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Guangzhou Improve Med Instrument's current assets represent 47.4% of total assets in 2024, a decrease from 70.3% in 2006.
- Cash Position: Cash and equivalents constituted 19.9% of total assets in 2024, up from 9.0% in 2006.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, unchanged from 3.0% in 2006.
- Asset Diversification: The largest asset category is accounts receivable at 13.3% of total assets.
Guangzhou Improve Med Instrument Competitors by Total Assets
Key competitors of Guangzhou Improve Med Instrument based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931
|
China | CN¥3.82 Billion |
|
Blue Sail Medical Co Ltd
SHE:002382
|
China | CN¥16.46 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥28.98 Billion |
|
Allmed Medical Products Co Ltd Class A
SHE:002950
|
China | CN¥5.35 Billion |
|
Inix Technologies Holdings Bhd
KLSE:0094
|
Malaysia | RM72.53 Million |
|
Focus Point Holdings Bhd
KLSE:0157
|
Malaysia | RM328.19 Million |
|
Careplus Group Bhd
KLSE:0163
|
Malaysia | RM286.61 Million |
|
LKL International Bhd
KLSE:0182
|
Malaysia | RM173.46 Million |
Guangzhou Improve Med Instrument - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Guangzhou Improve Med Instrument generates 0.47x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Guangzhou Improve Med Instrument is currently not profitable relative to its asset base.
Guangzhou Improve Med Instrument - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.26 | 1.16 | 1.85 |
| Quick Ratio | 0.99 | 0.91 | 1.53 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥91.37 Million | CN¥ 84.39 Million | CN¥ 395.41 Million |
Guangzhou Improve Med Instrument - Advanced Valuation Insights
This section examines the relationship between Guangzhou Improve Med Instrument's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.08 |
| Latest Market Cap to Assets Ratio | 0.19 |
| Asset Growth Rate (YoY) | -12.7% |
| Total Assets | CN¥1.24 Billion |
| Market Capitalization | $234.74 Million USD |
Valuation Analysis
Below Book Valuation: The market values Guangzhou Improve Med Instrument's assets below their book value (0.19 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Guangzhou Improve Med Instrument's assets decreased by 12.7% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Guangzhou Improve Med Instrument (2006–2024)
The table below shows the annual total assets of Guangzhou Improve Med Instrument from 2006 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.24 Billion | -12.75% |
| 2023-12-31 | CN¥1.43 Billion | -8.49% |
| 2022-12-31 | CN¥1.56 Billion | -14.62% |
| 2021-12-31 | CN¥1.83 Billion | +4.60% |
| 2020-12-31 | CN¥1.74 Billion | +15.79% |
| 2019-12-31 | CN¥1.51 Billion | -0.29% |
| 2018-12-31 | CN¥1.51 Billion | -13.44% |
| 2017-12-31 | CN¥1.75 Billion | +18.78% |
| 2016-12-31 | CN¥1.47 Billion | +2.12% |
| 2015-12-31 | CN¥1.44 Billion | +41.20% |
| 2014-12-31 | CN¥1.02 Billion | +15.43% |
| 2013-12-31 | CN¥883.08 Million | +15.20% |
| 2012-12-31 | CN¥766.53 Million | +6.95% |
| 2011-12-31 | CN¥716.72 Million | +10.05% |
| 2010-12-31 | CN¥651.24 Million | -1.00% |
| 2009-12-31 | CN¥657.84 Million | +364.29% |
| 2008-12-31 | CN¥141.69 Million | +91.78% |
| 2007-12-31 | CN¥73.88 Million | +84.93% |
| 2006-12-31 | CN¥39.95 Million | -- |